Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation
- PMID: 17196864
- DOI: 10.1016/j.tracli.2006.11.004
Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation
Abstract
Over the past few decades, transfusion medicine and haemotherapy have evolved into complex medical disciplines comprising a broad field of subspecialties such as immunohaematology, blood component production, haemapheresis and haemostaseology. Transfusion medicine is thus an important qualification at the interfaces of analytical laboratory medicine, pharmaceutical production and clinical disciplines such as internal medicine, anaesthesiology or surgery. Physicians specialising in transfusion medicine are valuable and competent partners for these related disciplines when it comes to safe, effective and tailored haemotherapy. Why has transfusion medicine become so complex? On the one hand, one can discern problems such as infectious diseases like the HIV disaster in the past century, resulting in guidelines, directives and laws such as the transfusion law in Germany. Thereby, we now enjoy the highest level of blood product safety ever regarding viral transmission thanks to the broad implementation of PCR testing. On the other hand, there are numerous positive reasons for the increasing complexity of transfusion medicine: Modern medical therapies like stem cell transplantation, cellular therapy, transplantation of solid organs, regenerative medicine and surgery cannot exist without a safe supply of blood products and high quality standard as well as special blood products and laboratory services provided by blood banks and transfusion medicine specialists. Good laboratory practice (GLP), good manufacturing practice (GMP), quality management systems and quality control on the pharmaceutical manufacturer's level are only few examples of the standards in today's blood banking. European directives in the field of blood products, stem cell preparations and tissue have led to higher uniform quality standards for biological preparations in a unified Europe, which is the desired outcome, but which also increases the complexity of this field. In contrast, directives 93/16/EEC and 2001/19/EC, the directives of the European Parliament and of the Council on the mutual recognition of professional qualifications of European doctors currently in force, as well as the impending directive 2005/36/EC, which has to be translated into national law until October 2007, do not include transfusion medicine, blood transfusion or immunohaematology at all. Other medical specialities, which like our field, are not common to all member states of the European Union, are listed in the above mentioned directives with the minimum length of training and minimal requirements for the qualifications. Examples include clinical biology, biological haematology, microbiology-bacteriology, biological chemistry, immunology, thoracic, paediatric or vascular surgery as well as physiotherapy, stomatology, neuro-psychiatry, dermato-venerology, occupational medicine, allergology, geriatrics, gastro-enterological surgery, community medicine, nuclear medicine, pharmacology, accident and emergency medicine or tropical medicine. Most of the above are medical specialities in some member states, but not in all. A concerted initiative inaugurated by the European Network of Transfusion Medicine Societies (EuroNet-TMS) and the European Blood Alliance (EBA) aims to compile the situation of the transfusion medicine speciality throughout Europe. A preliminary summary of the current situation in 15 European states was prepared in 2005 after a first set of questions, which was sent out by us via the EBA platform. The authors appreciate Clair Watts' compilation of the answers provided by the 15 European colleagues. A summary of these answers is depicted in Table 1. However, the initiative aims at a more complex analysis of the different requirements and constituent parts of the qualification in transfusion medicine in different countries. A long-term objective of this initiative might be to introduce the transfusion medicine specialisation into the above mentioned EC directives in order to facilitate mutual recognition of transfusion medicine qualifications throughout Europe.
Similar articles
-
[The European network of transfusion medicine societies (EuroNet-TMS): The White Book 2005].Transfus Clin Biol. 2005 Jun;12(2):83-92. doi: 10.1016/j.tracli.2005.04.028. Transfus Clin Biol. 2005. PMID: 15896994 Review. French.
-
[New Croatian legislation on tissue banking].Acta Med Croatica. 2007 Dec;61(5):445-7. Acta Med Croatica. 2007. PMID: 18350803 Croatian.
-
[European Blood Alliance (EBA) and EuroNet TMS: what challenges for the transfusion of tomorrow?].Transfus Clin Biol. 2011 Apr;18(2):106-14. doi: 10.1016/j.tracli.2011.02.016. Epub 2011 Mar 31. Transfus Clin Biol. 2011. PMID: 21458349 Review. French.
-
"Eurocode International Blood Labeling System" enables unique identification of all biological products from human origin in accordance with the European Directive 2004/23/EC.Cell Tissue Bank. 2010 Nov;11(4):345-52. doi: 10.1007/s10561-010-9186-4. Epub 2010 Jun 20. Cell Tissue Bank. 2010. PMID: 20563859
-
[Transfusion medicine in unified Europe].Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:12-5. Infusionsther Transfusionsmed. 1994. PMID: 7841774 German.
Cited by
-
Global survey of transfusion medicine curricula in medical schools: Challenges and opportunities.Transfusion. 2021 Feb;61(2):617-626. doi: 10.1111/trf.16147. Epub 2020 Oct 22. Transfusion. 2021. PMID: 33091965 Free PMC article.
-
Advances in cellular therapy for the treatment of thyroid cancer.J Oncol. 2010;2010:179491. doi: 10.1155/2010/179491. Epub 2010 Jun 29. J Oncol. 2010. PMID: 20671939 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous